Skip to content
Screener

Abbott ABT Diagnostic Products — Net Sales

Other segment segments

Medical Devices
$5.85B+9.0%
Nutritional Products
$2.14B-3.1%
Established Pharmaceuticals
$1.5B+8.4%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOClinical Diagnostics — Net Sales
$363.6M+1.9%
Motorola Solutions, Inc. logo
MSIProducts — Net Sales
$1.48B+2.3%
SOL
SOLSProducts — Net Sales
$915M+9.2%
Honeywell International logo
HONProducts — Net Sales
$1.02B-10.8%
Raytheon Technologies logo
RTXProducts — Net Sales
$17.94B+15.4%
Enerpac Tool Group logo
EPACProducts — Net Sales
$133.53M+7.4%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$182.9B-19.1%
Enterprise value$210.41B-9.6%
P/E33.7×+17.5×
P/S3.9×-1.3×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
(in millions)Three Months Ended June 30, 2026 / U.S.Three Months Ended June 30, 2026 / Int’lThree Months Ended June 30, 2026 / TotalThree Months Ended June 30, 2025 / U.S.Three Months Ended June 30, 2025 / Int’lThree Months Ended June 30, 2025 / Total
Core Laboratory3771,0411,4183511,0071,358
Rapid and Molecular393362755460355815
Cancer Diagnostics89029919———
Total1,6601,4323,0928111,3622,173
Medical Devices —
Rhythm Management377366743340333673
Electrophysiology420441861362393755
Heart Failure3138840128286368

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's diagnostic products — net sales?
Abbott (ABT) reported diagnostic products — net sales of $3.09B in Q2 2026.
How has Abbott's diagnostic products — net sales changed year-over-year?
Abbott's diagnostic products — net sales increased by 42.3% year-over-year, from $2.17B to $3.09B.
What is the long-term trend for Abbott's diagnostic products — net sales?
Over 4 years (2021 to 2025), Abbott's diagnostic products — net sales has grown at a -13.1% compound annual growth rate (CAGR), from $15.64B to $8.94B.
What does diagnostic products — net sales mean?
Represents the total revenue generated from the sale of diagnostic equipment, testing kits, and related services within the diagnostics business segment. This figure reflects the market demand for the company's laboratory and point-of-care testing solutions before deducting any operating expenses.

Ask your AI about Abbott's diagnostic products — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude